← Scroll for more →
Financial Statements — GUTS
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 47.14 | 63.17 | 81.54 | 77.66 | 22.29 | 42.11 | 67.46 | 84.66 | 102.44 | 121.44 |
| Accounts Receivable | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | 0.02 | 0.02 |
| Inventory | -- | -- | -- | -- | -- | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 |
| Total Current Assets | 49.60 | 65.92 | 87.58 | 79.70 | 26.69 | 47.05 | 71.76 | 87.65 | 106.56 | 124.47 |
| Property, Plant & Equipment | 1.85 | 2.13 | 2.41 | 2.68 | 2.97 | 3.14 | 2.98 | 3.00 | 3.17 | 1.90 |
| Total Non-current Assets* | 32.37 | 33.47 | 33.83 | 34.57 | 35.32 | 35.99 | 36.31 | 39.27 | 39.88 | 39.05 |
| Total Assets | 81.98 | 99.39 | 121.40 | 114.27 | 62.01 | 83.04 | 108.08 | 126.92 | 146.44 | 163.52 |
| Accounts Payable | 1.01 | 1.65 | 1.57 | 1.26 | 3.91 | 1.48 | 3.24 | 1.77 | 2.29 | 1.03 |
| Total Current Liabilities | 15.74 | 15.41 | 18.33 | 18.68 | 21.83 | 18.80 | 19.77 | 15.72 | 14.28 | 13.27 |
| Total Non-current Liabilities* | 67.91 | 62.60 | 93.62 | 98.77 | 58.39 | 57.86 | 59.88 | 60.89 | 61.40 | 66.07 |
| Total Liabilities | 83.64 | 78.01 | 111.94 | 117.45 | 80.22 | 76.67 | 79.65 | 76.60 | 75.68 | 79.34 |
| Retained Earnings | (572.58) | (547.05) | (556.26) | (512.54) | (466.93) | (439.04) | (415.31) | (390.34) | (367.17) | (349.94) |
| Total Stockholder Equity | (1.66) | 21.38 | 9.46 | (3.18) | (18.21) | 6.38 | 28.42 | 50.32 | 70.76 | 84.18 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | -- | -- | -- | -- | -- | -- | 0.00 | 0.01 | 0.04 | 0.03 |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | 0.00 | 0.01 | 0.02 | 0.02 |
| Gross Profit | -- | -- | -- | -- | -- | -- | 0.00 | 0.01 | 0.02 | 0.01 |
| Research & Development | 13.81 | 15.60 | 16.49 | 17.46 | 21.15 | 19.43 | 20.28 | 19.00 | 16.76 | 14.42 |
| Selling, General & Admin | 5.28 | 5.22 | 6.79 | 5.24 | 4.93 | 5.32 | 4.93 | 4.80 | 6.24 | 7.13 |
| Total Operating Expenses | 19.10 | 20.82 | 23.28 | 22.69 | 26.08 | 24.76 | 25.21 | 23.80 | 23.00 | 21.56 |
| Operating Income | (19.10) | (20.82) | (23.28) | (22.69) | (26.08) | (24.76) | (25.21) | (23.79) | (22.98) | (21.54) |
| Net Income | (25.54) | 9.22 | (43.73) | (45.60) | (27.89) | (23.73) | (24.97) | (23.17) | (17.23) | (3.32) |
| Basic EPS | (0.16) | 0.06 | (1.08) | (0.71) | (0.57) | (0.49) | (7.32) | (0.48) | (0.36) | (0.17) |
| Diluted EPS | (0.16) | 0.06 | (1.08) | (0.71) | (0.57) | (0.49) | (7.32) | (0.48) | (0.36) | (0.17) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (15.90) | (22.48) | (21.34) | (22.71) | (21.20) | (25.08) | (17.03) | (18.04) | (18.74) | (11.71) |
| Capital Expenditures | -- | -- | 0.00 | 0.01 | 0.10 | 0.45 | 0.23 | 0.21 | 0.26 | 1.06 |
| Free Cash Flow* | -- | -- | (21.34) | (22.72) | (21.30) | (25.53) | (17.27) | (18.25) | (19.00) | (12.77) |
| Investing Cash Flow | -- | -- | -0.00 | (0.01) | (0.10) | (0.45) | (0.23) | (0.21) | (0.26) | (1.06) |
| Financing Cash Flow | (0.13) | 4.11 | 25.22 | 78.09 | 1.48 | 0.17 | 0.07 | 0.16 | -0.00 | 101.00 |
← Scroll for more columns →
* Derived from reported values